Inflammation Mediated Hepcidin-Ferroportin Pathway and Its Therapeutic Window in Breast Cancer
Tewodros Shibabaw,1 Banchamlak Teferi,2 Meseret Derbew Molla,1 Birhanu Ayelign3 1Department of Biochemistry, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia; 2Department of Clinical Pharmacy, School of Pharmacy, College of Medicine and Health Scien...
Guardado en:
Autores principales: | Shibabaw T, Teferi B, Molla MD, Ayelign B |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/150abe3656a249b69d3eb6f148ba339a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Novel Pathways for Targeting Tumor Angiogenesis in Metastatic Breast Cancer
por: Jordan A. Harry, et al.
Publicado: (2021) -
STAT5 is activated in macrophages by breast cancer cell-derived factors and regulates macrophage function in the tumor microenvironment
por: Emily A. Jesser, et al.
Publicado: (2021) -
The Dual Effect of the BMP9–ALK1 Pathway in Blood Vessels: An Opportunity for Cancer Therapy Improvement?
por: Blanca Ayuso-Íñigo, et al.
Publicado: (2021) -
Prognostic Impact of Tumor-Associated Macrophages on Long-Term Oncologic Outcomes in Colorectal Cancer
por: Hyeong Chan Shin, et al.
Publicado: (2021) -
The Neglected Liaison: Targeting Cancer Cell Metabolic Reprogramming Modifies the Composition of Non-Malignant Populations of the Tumor Microenvironment
por: Maria Iorio, et al.
Publicado: (2021)